Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Globus Medical (GMED)

Globus Medical director John DeFord resigns from board effective immediately

Neutral Impact 2 of 5 leadership Written later

Globus Medical director John A. DeFord, Ph.D., resigned from the Board of Directors effective immediately on March 23, 2026, and said the decision was not a result of any disagreement with the company. He will not seek re-election at the Annual Meeting of Stockholders on June 3, 2026. The filing describes a board departure with no change to financial results or guidance.

Key points

  • Resignation effective immediately, announced March 23, 2026
  • Company states the decision was not due to any disagreement with the company
  • Dr. DeFord would not have stood for re-election at the June 3, 2026 annual meeting
  • Chairman David C. Paul thanked him for his work on the NuVasive merger and the Nominating and Governance Committee

The filing

CompanyGlobus Medical (GMED)
Form8-K, current report
Filed with the SECMar 23, 2026, 5:26 PM ET
Accession number0001628280-26-020612

Items reported: 5.02 Director / Officer Change7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.